• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: June 2020

Pharma & Human Health

UC San Diego Center for Microbiome Innovation Adds Two Petabytes of Panasas’ HPC Storage for COVID-19 Research

June 30, 2020 Microbiome Times

Researchers at the UC San Diego Center for Microbiome Innovation (CMI), the world’s leading microbiome research organization, have expanded their Panasas® high-performance computing (HPC) storage infrastructure with an additional two petabytes of ActiveStor® data storage […]

Pharma & Human Health

IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders

June 30, 2020 Microbiome Times

The recently published Clinical Practice Guidelines on the role of probiotics in the management of gastrointestinal disorders by the American Gastroenterological Association (AGA) contains some points of discussion, celebration, and contention for the probiotic field. […]

Finance

Boost Biomes announces close of Series A and co-development agreement for biostimulants products

June 29, 2020 Microbiome Times

US-based food and agriculture biotech startup Boost Biomes and global crop nutrition company, Yara International ASA, announced today the close of Boost’s USD 5 million series A equity round as well as a joint development […]

Finance

Novozymes acquires PrecisionBiotics Group to advance its business within human health

June 26, 2020 Microbiome Times

Novozymes announced that it has acquired PrecisionBiotics Group Limited. Based in Cork, Ireland, PrecisionBiotics Group holds a leading position within probiotics for human gut health and is well positioned with several clinically backed products already […]

Finance

Enterome Completes €46.3 Million Financing to Progress the Clinical Development of Its Therapeutic Pipeline

June 25, 2020 Microbiome Times

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today announces a new financing totaling €46.3 million ($52.6million) to progress the clinical development of its therapeutic […]

Pharma & Human Health

Pioneering research reveals certain human genes relate to gut bacteria

June 24, 2020 Microbiome Times

The role genetics and gut bacteria play in human health has long been a fruitful source of scientific enquiry, but new research marks a significant step forward in unraveling this complex relationship. Its findings could […]

Pharma & Human Health

Live Biotherapeutic Products – a new regulatory approach for the safety assessment of a specific category of biological medicinal products

June 22, 2020 Microbiome Times

An article has been published in Frontiers in Medicine: Regulatory Science section, which proposes a new set of recommendations for addressing the various regulatory and technical challenges when assessing the safety of Live Biotherapeutic Products […]

Pharma & Human Health

Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics

June 18, 2020 Microbiome Times

Metabolon, Inc., the global leader in metabolomics, and DNA Genotek, a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), have collaborated to bring OMNImet™·GUT, the first device for in-home collection and ambient-temperature storage and shipping of […]

Pharma & Human Health

New microbiome research of practical value to patients

June 16, 2020 Microbiome Times

Two of the most important and largest microbiome studies ever undertaken in patients with chronic inflammatory bowel disease have been conducted by a team of researchers in Cork from APC Microbiome Ireland. The research, which […]

Pharma & Human Health

Stakeholders in microbiome-based therapeutic development convene to address the lack of clarity and standards for OMICS data

June 15, 2020 Kristina Campbell

Despite more than 200 companies worldwide actively developing microbiome-based therapeutics, both the pre-clinical and clinical development of these drug products is fraught with uncertainty. Data generated from R&D activities on a microbiome-related drug product are […]

Finance

Debiopharm’s Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders

June 10, 2020 Microbiome Times

Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today an exclusive license agreement and research collaboration with Takeda Pharmaceutical Company Limited (Takeda) to develop novel microbiome therapeutics for the treatment of gastrointestinal (GI) disorders. The preclinical program […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
sign up

Sign up to the Microbiome Times newsletter